Extracts deal risk and MEDDPICC data from sales calls and emails to build action plans automatically.
Dealwize reads sales call transcripts and emails to build mutual action plans, score deals against the MEDDPICC framework, flag stalled or at-risk deals early, and track how engaged a buyer actually is. It is aimed at B2B sales teams who currently track this information by hand in spreadsheets or a CRM's free-text fields. The company behind it, Curious Angle Limited, is registered in London. Plans are billed monthly by usage tier rather than by seat count alone, and a 14-day trial requires no card; the site also mentions a lightweight, no-signup way to get a one-off deal analysis by submitting a call transcript.
Starter is $49/month for 5 deal boards and 20 AI extractions; Professional is $99/month and Scale is $179/month, each raising board, extraction, and seat limits.
Use tool ↗Dealwize targets a specific pain: reps and managers manually reconstructing deal health from call notes. Automating MEDDPICC extraction and risk flags from existing calls and emails is a real time-saver if a team already runs disciplined deal reviews, less so for teams without that process to plug into.
No reviews yet — be the first to review Dealwize.
Reviews are tied to your EffectHub account — one review per tool, so the rating for Dealwize reflects real users.
No questions yet — ask the first one about Dealwize.
Questions about Dealwize are tied to your EffectHub account, so answers can reach you and the section stays free of spam.